| Mr. Paul Sekhri |
Non-Executive Independent Chairman of the Board |
63 |
- |
Male |
|
| Dr. Anat Cohen-Dayag |
President, Chief Executive Officer, Director |
55 |
$1.301M - USD |
Female |
|
| Mr. Ari Krashin |
Chief Financial Officer, Chief Operating Officer |
49 |
$766.2K - USD |
Male |
|
| Dr. Henry Adewoye |
Senior Vice President, Chief Medical Officer |
57 |
$836.9K - USD |
Male |
|
| Dr. Oliver Froescheis |
Senior Vice President, Corporate and Business Development |
56 |
$666.3K - USD |
Male |
|
| Dr. Zurit Levine |
Senior Vice President, Technology Innovation |
54 |
$478.7K - USD |
Female |
|
| Dr. Yaron Turpaz |
Senior Vice President, Senior Advisor, Computational Discovery |
51 |
- |
Male |
|
| Mr. Eran Ophir |
Vice President - Research, Drug Discovery |
44 |
- |
Male |
|
| Mr. Gilead Halevy |
Independent Director |
55 |
- |
Male |
|
| Dr. Kinneret Livnat Savitsky |
Independent Director |
55 |
- |
Female |
|
| Mr. Eran Perry |
Independent Director |
51 |
- |
Male |
|
| Mr. Sanford Zweifach |
Independent Director |
64 |
- |
Male |
|
| Ms. Yvonne Naughton |
Head of Investor Relations and Corporate Communications |
|
- |
Female |
|
